|BIBCL -- India Stock|| |
INR 8.07 0.17 2.15%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Bharat Immunologicals Profit Margin Analysis
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Bharat Immunologicals ValuationFundamentalsBuy or Sell
|Bharat Immunologicals ||Profit Margin|| = |
About Profit Margin
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Profit Margin of -6.64%. This is 40.77% lower than that of the Healthcare sector, and 71.17% lower than that of Biotechnology
industry, The Profit Margin for all stocks is 422.83% higher than the company.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is number one stock in price to earning category among related companies. It is number one stock in gross profit category among related companies fabricating about 394,286
of Gross Profit per Price to Earning.
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bharat Immunologicals current financial ratios